2.80
전일 마감가:
$2.74
열려 있는:
$2.74
하루 거래량:
1.27M
Relative Volume:
0.67
시가총액:
$216.57M
수익:
$10.42B
순이익/손실:
$-38.77M
주가수익비율:
-5.4902
EPS:
-0.51
순현금흐름:
$323.54M
1주 성능:
+0.00%
1개월 성능:
-9.68%
6개월 성능:
-64.69%
1년 성능:
-80.74%
오웬스 앤 마이너 Stock (OMI) Company Profile
명칭
Accendra Health Inc
전화
(804) 723-7000
주소
10900 NUCKOLS ROAD, GLEN ALLEN, VA
OMI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
|
MCK
Mckesson Corporation
|
840.46 | 104.19B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
354.85 | 68.94B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
212.45 | 50.72B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
79.98 | 9.19B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5902 | 840.28M | 2.22M | -5.63M | -1.68M | -0.24 |
오웬스 앤 마이너 Stock (OMI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-07-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-12 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | 재개 | Citigroup | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-30 | 재개 | JP Morgan | Underweight |
| 2020-12-17 | 업그레이드 | UBS | Neutral → Buy |
| 2020-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-05-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-01-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-06 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-10 | 재확인 | BofA/Merrill | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-11-01 | 재확인 | Barclays | Underweight |
| 2018-10-31 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-03-08 | 개시 | Barclays | Underweight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2017-12-19 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-01 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2016-11-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2016-04-21 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2016-03-16 | 개시 | Credit Suisse | Underperform |
| 2015-12-07 | 재확인 | RBC Capital Mkts | Sector Perform |
모두보기
오웬스 앤 마이너 주식(OMI)의 최신 뉴스
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Owens & Minor, Inc. (OMI) Stock Analysis: Evaluating the 94.29% Potential Upside for Investors - DirectorsTalk Interviews
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) EV-to-OCF : -23.35 (As of Jan. 07, 2026) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView — Track All Markets
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Diluted net income available to common stockholders of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Net current asset value per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc.: Target Price Consensus and Analysts Recommendations | 6OM | US6907321029 - MarketScreener
Accendra Health, Inc.: Revenue and Earnings Analysts Forecasts Revisions | 6OM | US6907321029 - MarketScreener
Accendra Health begins trading on NYSE under new ticker symbol By Investing.com - Investing.com Nigeria
Accendra Health Inc (NYSE: ACH)Related Research - intelligentinvestor.com.au
6OM: Static price chart | Accendra Health, Inc. | US6907321029 - MarketScreener
Platinum Equity Completes Acquisition of Owens & Minor Products & Healthcare Services Business - Platinum Equity
Owens & Minor rebrands after $375M sale of largest division - Virginia Business
Two execs exit Accendra Health as Products & Healthcare Services sale closes - HME News
ACH Stock Price Today - Stock Titan
Two new option listings and three option delistings on January 2nd - TipRanks
Owens & Minor (OMI) Options to be Delisted in Early January - GuruFocus
Platinum Equity Completes Acquisition Of Owens & Minor Products & Healthcare Services Business - Pulse 2.0
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Accendra Health begins trading on NYSE under new ticker symbol - Investing.com
Accendra Health to Begin Trading on NYSE under New Ticker “ACH” - TradingView — Track All Markets
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH” - FinancialContent
Accendra Health, Inc.: Top Mutual Funds Holders | OMI | US6907321029 - MarketScreener
Owens & Minor, Inc. will Change its Ticker to ACH from OMI - marketscreener.com
Owens & Minor completes sale, transforms to Accendra Health - MSN
Owens & Minor completes sale of products segment, rebrands as Accendra - Investing.com Nigeria
Owens & Minor completes sale of products & healthcare services business to Platinum Equity - MarketScreener
Owens & Minor Completes Sale, Transforms to Accendra Health - TipRanks
Owens & Minor Sells Products & Healthcare Services Segment for $375 Million - marketscreener.com
Accendra Health Signs Multiple Financing Agreements - TradingView — Track All Markets
Owens & Minor completes sale of products segment, rebrands as Accendra By Investing.com - Investing.com South Africa
PLATINUM EQUITY COMPLETES ACQUISITION OF OWENS & MINOR PRODUCTS & HEALTHCARE SERVICES BUSINESS - PR Newswire
Owens & Minor, Inc. Announces Executive Changes, Effective December 31, 2025 - marketscreener.com
Owens & Minor (NYSE: OMI) closes $375M P&HS sale and adopts Accendra Health name - Stock Titan
오웬스 앤 마이너 (OMI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
오웬스 앤 마이너 주식 (OMI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 09 '25 |
Buy |
7.39 |
225,000 |
1,662,750 |
11,482,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 08 '25 |
Buy |
7.96 |
105,000 |
835,800 |
11,257,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 10 '25 |
Buy |
7.19 |
80,000 |
575,200 |
11,562,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 07 '25 |
Buy |
7.84 |
240,000 |
1,881,600 |
11,152,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 03 '25 |
Buy |
8.53 |
160,000 |
1,364,800 |
10,784,599 |
| Coliseum Capital Management, L | 10% Owner |
Apr 04 '25 |
Buy |
8.14 |
128,356 |
1,044,818 |
10,912,955 |
| Coliseum Capital Management, L | 10% Owner |
Feb 28 '25 |
Buy |
9.39 |
1,738,511 |
16,324,618 |
9,469,698 |
| Coliseum Capital Management, L | 10% Owner |
Mar 04 '25 |
Buy |
9.75 |
800,000 |
7,800,000 |
10,624,599 |
자본화:
|
볼륨(24시간):